Phase II study evaluating the combination of capecitabine and oxaliplatin in patients with gastric cancer

Trial Profile

Phase II study evaluating the combination of capecitabine and oxaliplatin in patients with gastric cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Nov 2015

At a glance

  • Drugs Capecitabine (Primary) ; Oxaliplatin
  • Indications Gastric cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Nov 2015 Results published in Chugai Pharmaceuticals media release.
    • 20 Nov 2015 According to Chugai Pharmaceuticals media release, company announced that it has obtained supplemental approval from the Japanese Ministry of Health, Labour and Welfare (MHLW).
    • 31 Jul 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top